Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
10th Conference of the Canadian Blood and Marrow Transplant Group
CML Standard of Care: Reviewing the Updated Recommendations
Edmonton, Alberta / April 21-24, 2006
Edmonton - In patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML), the tyrosine kinase inhibitior (TKI) imatinib has become the gold standard of therapy. Long-term results from IRIS (International Randomized Trial...
EUROGIN 2006 6th International Multidisciplinary Congress
Emerging Issues on Human Papillomavirus Prophylactic Vaccines
Paris, France / April 23-26, 2006
Paris - Among important issues addressed here during the scientific sessions was the durability of long-term protection by human papillomavirus (HPV) vaccination and how women infected prior to vaccination with one or more of the HPV types...
10th Biennial Meeting of the Canadian Blood and Marrow Transplant Group
Expanding Therapeutic Options for Chronic Myeloid Leukemia
Edmonton, Alberta / April 21-24, 2006
Edmonton - The arrival of imatinib as a targeted therapeutic option for chronic myeloid leukemia (CML) has been a highly encouraging development for the prognosis for this disease, and for patients who achieve a good early response to...
31st Annual Meeting Association des médecins hématologues et oncologues du Québec
New Prognostic and Therapeutic Opportunities in Chronic Lymphocytic Leukemia
Vaudreuil, Quebec / April 20-23, 2006
Vaudreuil - Once considered nearly exclusively an indolent disease of the elderly, chronic lymphocytic leukemia (CLL) is becoming more common in younger individuals. Aggressive therapy may be more desirable for patients in this age group....
21st Annual Congress of the European Association of Urology
Finding the Key to Dihydrotestosterone Control in Prostate Cancer Prevention
Paris, France / April 5-8, 2006
Paris - Dihydrotestosterone (DHT) plays a central role in both normal and abnormal prostate growth. Manipulation of DHT levels via inhibition of the enzyme 5 alpha-reductase (5AR) has proven to be an effective means of treating benign...
21st Annual Congress of the European Association of Urology
Multikinase Inhibition in the Management of Renal Cell Carcinoma: The Role of Urologists
Paris, France / April 5-8, 2006
Paris - Greater understanding of molecular biology and the impact of genetic mutations on intracellular pathways in kidney cancer cells has led to the identification of several receptors and signalling molecules as targets for the treatment...
21st Annual Congress of the European Association of Urology
A Relevant Therapeutic Target for Patients with Benign Prostatic Hyperplasia
Paris, France / April 5-8, 2006
Paris - Despite a sustained increase in the use of medical therapy for symptomatic benign prostatic hyperplasia (BPH) in recent years, watchful waiting has remained the North American treatment of choice for BPH below the threshold for...
Based on the following article: J Am Soc Nephrol 2006;17(2):581-9
Immunosuppressive Regimens and Cancer Risk: Are All Anti-rejection Treatments the Same?
Transplantation March 2006
Reported by: G.V. Ramesh Prasad, MB, BS, MSc, FRCPC Assistant Professor of Medicine University of Toronto Toronto, Ontario Staff Physician St. Michael’s Hospital Toronto, Ontario As discussed by Dr. Josep Campistol, Provincial...
2nd European Congress on Hematologic Malignancies
Improving Survival in Follicular Lymphoma
Barcelona, Spain / February 24-26, 2006
Barcelona - The natural history of follicular non-Hodgkin’s lymphoma (NHL) following initial therapy is characterized by repeated relapses of increasingly shorter duration leading ultimately to death from progressive disease. Several...